サマリー

細胞治療の世界市場 2023-2027
細胞治療市場は、2022年から2027年にかけて31,041.49百万米ドルの成長が予測され、予測期間中のCAGRは57.06%で加速すると予測されています。この調査レポートは、細胞治療市場の全体的な分析、市場規模と予測、動向、成長促進要因、課題、さらに約25のベンダーを網羅したベンダー分析などを掲載しています。
現在の市場シナリオ、最新動向と促進要因、市場環境全体に関する最新分析を提供しています。市場は、従来の臓器移植の制限が細胞療法の需要を後押ししていること、細胞ベースの研究における資金調達が増加していること、CAR T細胞療法の有効性が実証されていることなどが原動力となっています。
Technavioの細胞療法市場は以下のように区分される：
タイプ別
- 自家
- 同種異系
用途別
- 悪性腫瘍
- 筋骨格系
- 心血管
- その他
地域別
- 北米
- ヨーロッパ
- アジア
- その他の地域（ROW）
本調査では、今後数年間の細胞療法市場の成長を促進する主な理由の一つとして、細胞療法製品への注目の高まりを挙げている。また、細胞治療市場における戦略的提携やワクチン生産の増加は、市場の大きな需要につながる。
本レポートでは、細胞治療市場について以下の領域をカバーしています：
- 細胞治療市場のサイジング
- 細胞治療市場の予測
- 細胞治療市場の産業分析
本レポートでは、アステラス製薬、Athersys Inc.、Avita Medical Inc.、BioCardia Inc、BioSenicSA、Brainstorm Cell Therapeutics Inc.、Bristol Myers Squibb Co.、Capricor Therapeutics Inc.、Castle Creek Biosciences Inc.、CellSeed Inc.、Cellular Biomedicine Group Inc.、Celyad Oncology SA、Gilead Sciences Inc.、Lineage Cell Therapeutics Inc.、Lisata Therapeutics Inc.、Mesoblast Ltd.、Novartis AG、Pharmicell Co.Ltd.、Sanpower Group Co.Ltd.、ThermoGenesis Holdings Inc.また、細胞治療市場の分析レポートには、市場成長に影響を与える今後の動向や課題に関する情報も含まれています。これは、企業が戦略を練り、来るべき成長機会をすべて活用するのに役立つものである。
本調査は、業界の主要参加者からのインプットを含め、一次情報と二次情報を客観的に組み合わせて実施しました。本レポートには、主要ベンダーの分析に加え、包括的な市場およびベンダーランドスケープが含まれています。本レポートの詳細については、https://www.technavio.com/report/cell-therapy-market-industry-analysis をご覧ください。
当出版社では、利益、価格、競争、プロモーションなどの主要パラメータの分析により、複数の情報源からのデータを調査、統合、要約する方法で、市場の詳細なイメージを提示しています。また、主要な業界インフルエンサーを特定することで、市場の様々な側面を提示しています。提示されるデータは包括的で信頼性が高く、一次および二次にわたる広範な調査の結果です。市場調査レポートは、正確な市場成長を予測するために、完全な競争環境と、質的・量的調査を用いた綿密なベンダー選定方法と分析を提供します。

ページTOPに戻る

目次

• 1 Executive Summary
o 1.1 Market overview
o Exhibit 01: Executive Summary - Chart on Market Overview
o Exhibit 02: Executive Summary - Data Table on Market Overview
o Exhibit 03: Executive Summary - Chart on Global Market Characteristics
o Exhibit 04: Executive Summary - Chart on Market by Geography
o Exhibit 05: Executive Summary - Chart on Market Segmentation by Type
o Exhibit 06: Executive Summary - Chart on Market Segmentation by Application
o Exhibit 07: Executive Summary - Chart on Incremental Growth
o Exhibit 08: Executive Summary - Data Table on Incremental Growth
o Exhibit 09: Executive Summary - Chart on Vendor Market Positioning
• 2 Market Landscape
o 2.1 Market ecosystem
o Exhibit 10: Parent market
o Exhibit 11: Market Characteristics
• 3 Market Sizing
o 3.1 Market definition
o Exhibit 12: Offerings of vendors included in the market definition
o 3.2 Market segment analysis
o Exhibit 13: Market segments
o 3.3 Market size 2022
o 3.4 Market outlook: Forecast for 2022-2027
o Exhibit 14: Chart on Global - Market size and forecast 2022-2027 ($ million)
o Exhibit 15: Data Table on Global - Market size and forecast 2022-2027 ($ million)
o Exhibit 16: Chart on Global Market: Year-over-year growth 2022-2027 (%)
o Exhibit 17: Data Table on Global Market: Year-over-year growth 2022-2027 (%)
• 4 Historic Market Size
o 4.1 Global cell therapy market 2017 - 2021
o Exhibit 18: Historic Market Size - Data Table on global cell therapy market 2017 - 2021 ($ million)
o 4.2 Type Segment Analysis 2017 - 2021
o Exhibit 19: Historic Market Size - Type Segment 2017 - 2021 ($ million)
o 4.3 Application Segment Analysis 2017 - 2021
o Exhibit 20: Historic Market Size - Application Segment 2017 - 2021 ($ million)
o 4.4 Geography Segment Analysis 2017 - 2021
o Exhibit 21: Historic Market Size - Geography Segment 2017 - 2021 ($ million)
o 4.5 Country Segment Analysis 2017 - 2021
o Exhibit 22: Historic Market Size - Country Segment 2017 - 2021 ($ million)
• 5 Five Forces Analysis
o 5.1 Five forces summary
o Exhibit 23: Five forces analysis - Comparison between 2022 and 2027
o 5.2 Bargaining power of buyers
o Exhibit 24: Chart on Bargaining power of buyers - Impact of key factors 2022 and 2027
o 5.3 Bargaining power of suppliers
o Exhibit 25: Bargaining power of suppliers - Impact of key factors in 2022 and 2027
o 5.4 Threat of new entrants
o Exhibit 26: Threat of new entrants - Impact of key factors in 2022 and 2027
o 5.5 Threat of substitutes
o Exhibit 27: Threat of substitutes - Impact of key factors in 2022 and 2027
o 5.6 Threat of rivalry
o Exhibit 28: Threat of rivalry - Impact of key factors in 2022 and 2027
o 5.7 Market condition
o Exhibit 29: Chart on Market condition - Five forces 2022 and 2027
• 6 Market Segmentation by Type
o 6.1 Market segments
o Exhibit 30: Chart on Type - Market share 2022-2027 (%)
o Exhibit 31: Data Table on Type - Market share 2022-2027 (%)
o 6.2 Comparison by Type
o Exhibit 32: Chart on Comparison by Type
o Exhibit 33: Data Table on Comparison by Type
o 6.3 Autologous - Market size and forecast 2022-2027
o Exhibit 34: Chart on Autologous - Market size and forecast 2022-2027 ($ million)
o Exhibit 35: Data Table on Autologous - Market size and forecast 2022-2027 ($ million)
o Exhibit 36: Chart on Autologous - Year-over-year growth 2022-2027 (%)
o Exhibit 37: Data Table on Autologous - Year-over-year growth 2022-2027 (%)
o 6.4 Allogenic - Market size and forecast 2022-2027
o Exhibit 38: Chart on Allogenic - Market size and forecast 2022-2027 ($ million)
o Exhibit 39: Data Table on Allogenic - Market size and forecast 2022-2027 ($ million)
o Exhibit 40: Chart on Allogenic - Year-over-year growth 2022-2027 (%)
o Exhibit 41: Data Table on Allogenic - Year-over-year growth 2022-2027 (%)
o 6.5 Market opportunity by Type
o Exhibit 42: Market opportunity by Type ($ million)
o Exhibit 43: Data Table on Market opportunity by Type ($ million)
• 7 Market Segmentation by Application
o 7.1 Market segments
o Exhibit 44: Chart on Application - Market share 2022-2027 (%)
o Exhibit 45: Data Table on Application - Market share 2022-2027 (%)
o 7.2 Comparison by Application
o Exhibit 46: Chart on Comparison by Application
o Exhibit 47: Data Table on Comparison by Application
o 7.3 Malignancies - Market size and forecast 2022-2027
o Exhibit 48: Chart on Malignancies - Market size and forecast 2022-2027 ($ million)
o Exhibit 49: Data Table on Malignancies - Market size and forecast 2022-2027 ($ million)
o Exhibit 50: Chart on Malignancies - Year-over-year growth 2022-2027 (%)
o Exhibit 51: Data Table on Malignancies - Year-over-year growth 2022-2027 (%)
o 7.4 Musculoskeletal - Market size and forecast 2022-2027
o Exhibit 52: Chart on Musculoskeletal - Market size and forecast 2022-2027 ($ million)
o Exhibit 53: Data Table on Musculoskeletal - Market size and forecast 2022-2027 ($ million)
o Exhibit 54: Chart on Musculoskeletal - Year-over-year growth 2022-2027 (%)
o Exhibit 55: Data Table on Musculoskeletal - Year-over-year growth 2022-2027 (%)
o 7.5 Cardiovascular - Market size and forecast 2022-2027
o Exhibit 56: Chart on Cardiovascular - Market size and forecast 2022-2027 ($ million)
o Exhibit 57: Data Table on Cardiovascular - Market size and forecast 2022-2027 ($ million)
o Exhibit 58: Chart on Cardiovascular - Year-over-year growth 2022-2027 (%)
o Exhibit 59: Data Table on Cardiovascular - Year-over-year growth 2022-2027 (%)
o 7.6 Others - Market size and forecast 2022-2027
o Exhibit 60: Chart on Others - Market size and forecast 2022-2027 ($ million)
o Exhibit 61: Data Table on Others - Market size and forecast 2022-2027 ($ million)
o Exhibit 62: Chart on Others - Year-over-year growth 2022-2027 (%)
o Exhibit 63: Data Table on Others - Year-over-year growth 2022-2027 (%)
o 7.7 Market opportunity by Application
o Exhibit 64: Market opportunity by Application ($ million)
o Exhibit 65: Data Table on Market opportunity by Application ($ million)
• 8 Customer Landscape
o 8.1 Customer landscape overview
o Exhibit 66: Analysis of price sensitivity, lifecycle, customer purchase basket, adoption rates, and purchase criteria
• 9 Geographic Landscape
o 9.1 Geographic segmentation
o Exhibit 67: Chart on Market share by geography 2022-2027 (%)
o Exhibit 68: Data Table on Market share by geography 2022-2027 (%)
o 9.2 Geographic comparison
o Exhibit 69: Chart on Geographic comparison
o Exhibit 70: Data Table on Geographic comparison
o 9.3 North America - Market size and forecast 2022-2027
o Exhibit 71: Chart on North America - Market size and forecast 2022-2027 ($ million)
o Exhibit 72: Data Table on North America - Market size and forecast 2022-2027 ($ million)
o Exhibit 73: Chart on North America - Year-over-year growth 2022-2027 (%)
o Exhibit 74: Data Table on North America - Year-over-year growth 2022-2027 (%)
o 9.4 Europe - Market size and forecast 2022-2027
o Exhibit 75: Chart on Europe - Market size and forecast 2022-2027 ($ million)
o Exhibit 76: Data Table on Europe - Market size and forecast 2022-2027 ($ million)
o Exhibit 77: Chart on Europe - Year-over-year growth 2022-2027 (%)
o Exhibit 78: Data Table on Europe - Year-over-year growth 2022-2027 (%)
o 9.5 Asia - Market size and forecast 2022-2027
o Exhibit 79: Chart on Asia - Market size and forecast 2022-2027 ($ million)
o Exhibit 80: Data Table on Asia - Market size and forecast 2022-2027 ($ million)
o Exhibit 81: Chart on Asia - Year-over-year growth 2022-2027 (%)
o Exhibit 82: Data Table on Asia - Year-over-year growth 2022-2027 (%)
o 9.6 Rest of World (ROW) - Market size and forecast 2022-2027
o Exhibit 83: Chart on Rest of World (ROW) - Market size and forecast 2022-2027 ($ million)
o Exhibit 84: Data Table on Rest of World (ROW) - Market size and forecast 2022-2027 ($ million)
o Exhibit 85: Chart on Rest of World (ROW) - Year-over-year growth 2022-2027 (%)
o Exhibit 86: Data Table on Rest of World (ROW) - Year-over-year growth 2022-2027 (%)
o 9.7 US - Market size and forecast 2022-2027
o Exhibit 87: Chart on US - Market size and forecast 2022-2027 ($ million)
o Exhibit 88: Data Table on US - Market size and forecast 2022-2027 ($ million)
o Exhibit 89: Chart on US - Year-over-year growth 2022-2027 (%)
o Exhibit 90: Data Table on US - Year-over-year growth 2022-2027 (%)
o 9.8 Germany - Market size and forecast 2022-2027
o Exhibit 91: Chart on Germany - Market size and forecast 2022-2027 ($ million)
o Exhibit 92: Data Table on Germany - Market size and forecast 2022-2027 ($ million)
o Exhibit 93: Chart on Germany - Year-over-year growth 2022-2027 (%)
o Exhibit 94: Data Table on Germany - Year-over-year growth 2022-2027 (%)
o 9.9 UK - Market size and forecast 2022-2027
o Exhibit 95: Chart on UK - Market size and forecast 2022-2027 ($ million)
o Exhibit 96: Data Table on UK - Market size and forecast 2022-2027 ($ million)
o Exhibit 97: Chart on UK - Year-over-year growth 2022-2027 (%)
o Exhibit 98: Data Table on UK - Year-over-year growth 2022-2027 (%)
o 9.10 China - Market size and forecast 2022-2027
o Exhibit 99: Chart on China - Market size and forecast 2022-2027 ($ million)
o Exhibit 100: Data Table on China - Market size and forecast 2022-2027 ($ million)
o Exhibit 101: Chart on China - Year-over-year growth 2022-2027 (%)
o Exhibit 102: Data Table on China - Year-over-year growth 2022-2027 (%)
o 9.11 Japan - Market size and forecast 2022-2027
o Exhibit 103: Chart on Japan - Market size and forecast 2022-2027 ($ million)
o Exhibit 104: Data Table on Japan - Market size and forecast 2022-2027 ($ million)
o Exhibit 105: Chart on Japan - Year-over-year growth 2022-2027 (%)
o Exhibit 106: Data Table on Japan - Year-over-year growth 2022-2027 (%)
o 9.12 Market opportunity by geography
o Exhibit 107: Market opportunity by geography ($ million)
o Exhibit 108: Data Tables on Market opportunity by geography ($ million)
• 10 Drivers, Challenges, and Trends
o 10.1 Market drivers
o 10.2 Market challenges
o 10.3 Impact of drivers and challenges
o Exhibit 109: Impact of drivers and challenges in 2022 and 2027
o 10.4 Market trends
• 11 Vendor Landscape
o 11.1 Overview
o 11.2 Vendor landscape
o Exhibit 110: Overview on Criticality of inputs and Factors of differentiation
o 11.3 Landscape disruption
o Exhibit 111: Overview on factors of disruption
o 11.4 Industry risks
o Exhibit 112: Impact of key risks on business
• 12 Vendor Analysis
o 12.1 Vendors covered
o Exhibit 113: Vendors covered
o 12.2 Market positioning of vendors
o Exhibit 114: Matrix on vendor position and classification
o 12.3 Astellas Pharma Inc.
o Exhibit 115: Astellas Pharma Inc. - Overview
o Exhibit 116: Astellas Pharma Inc. - Product / Service
o Exhibit 117: Astellas Pharma Inc. - Key news
o Exhibit 118: Astellas Pharma Inc. - Key offerings
o 12.4 Athersys Inc.
o Exhibit 119: Athersys Inc. - Overview
o Exhibit 120: Athersys Inc. - Product / Service
o Exhibit 121: Athersys Inc. - Key offerings
o 12.5 Avita Medical Inc.
o Exhibit 122: Avita Medical Inc. - Overview
o Exhibit 123: Avita Medical Inc. - Product / Service
o Exhibit 124: Avita Medical Inc. - Key offerings
o 12.6 BioCardia Inc.
o Exhibit 125: BioCardia Inc. - Overview
o Exhibit 126: BioCardia Inc. - Product / Service
o Exhibit 127: BioCardia Inc. - Key offerings
o 12.7 BioSenic SA
o Exhibit 128: BioSenic SA - Overview
o Exhibit 129: BioSenic SA - Product / Service
o Exhibit 130: BioSenic SA - Key offerings
o 12.8 Brainstorm Cell Therapeutics Inc.
o Exhibit 131: Brainstorm Cell Therapeutics Inc. - Overview
o Exhibit 132: Brainstorm Cell Therapeutics Inc. - Product / Service
o Exhibit 133: Brainstorm Cell Therapeutics Inc. - Key offerings
o 12.9 Bristol Myers Squibb Co.
o Exhibit 134: Bristol Myers Squibb Co. - Overview
o Exhibit 135: Bristol Myers Squibb Co. - Product / Service
o Exhibit 136: Bristol Myers Squibb Co. - Key news
o Exhibit 137: Bristol Myers Squibb Co. - Key offerings
o 12.10 Capricor Therapeutics Inc.
o Exhibit 138: Capricor Therapeutics Inc. - Overview
o Exhibit 139: Capricor Therapeutics Inc. - Product / Service
o Exhibit 140: Capricor Therapeutics Inc. - Key offerings
o 12.11 Castle Creek Biosciences Inc.
o Exhibit 141: Castle Creek Biosciences Inc. - Overview
o Exhibit 142: Castle Creek Biosciences Inc. - Product / Service
o Exhibit 143: Castle Creek Biosciences Inc. - Key offerings
o 12.12 CellSeed Inc.
o Exhibit 144: CellSeed Inc. - Overview
o Exhibit 145: CellSeed Inc. - Product / Service
o Exhibit 146: CellSeed Inc. - Key offerings
o 12.13 Cellular Biomedicine Group Inc.
o Exhibit 147: Cellular Biomedicine Group Inc. - Overview
o Exhibit 148: Cellular Biomedicine Group Inc. - Product / Service
o Exhibit 149: Cellular Biomedicine Group Inc. - Key offerings
o 12.14 Celyad Oncology SA
o Exhibit 150: Celyad Oncology SA - Overview
o Exhibit 151: Celyad Oncology SA - Product / Service
o Exhibit 152: Celyad Oncology SA - Key offerings
o 12.15 Gilead Sciences Inc.
o Exhibit 153: Gilead Sciences Inc. - Overview
o Exhibit 154: Gilead Sciences Inc. - Product / Service
o Exhibit 155: Gilead Sciences Inc. - Key news
o Exhibit 156: Gilead Sciences Inc. - Key offerings
o 12.16 Lineage Cell Therapeutics Inc.
o Exhibit 157: Lineage Cell Therapeutics Inc. - Overview
o Exhibit 158: Lineage Cell Therapeutics Inc. - Product / Service
o Exhibit 159: Lineage Cell Therapeutics Inc. - Key offerings
o 12.17 Lisata Therapeutics Inc.
o Exhibit 160: Lisata Therapeutics Inc. - Overview
o Exhibit 161: Lisata Therapeutics Inc. - Product / Service
o Exhibit 162: Lisata Therapeutics Inc. - Key offerings
• 13 Appendix
o 13.1 Scope of the report
o 13.2 Inclusions and exclusions checklist
o Exhibit 163: Inclusions checklist
o Exhibit 164: Exclusions checklist
o 13.3 Currency conversion rates for US$
o Exhibit 165: Currency conversion rates for US$
o 13.4 Research methodology
o Exhibit 166: Research methodology
o Exhibit 167: Validation techniques employed for market sizing
o Exhibit 168: Information sources
o 13.5 List of abbreviations
o Exhibit 169: List of abbreviations


Exhibits:
Exhibits1: Executive Summary - Chart on Market Overview
Exhibits2: Executive Summary - Data Table on Market Overview
Exhibits3: Executive Summary - Chart on Global Market Characteristics
Exhibits4: Executive Summary - Chart on Market by Geography
Exhibits5: Executive Summary - Chart on Market Segmentation by Type
Exhibits6: Executive Summary - Chart on Market Segmentation by Application
Exhibits7: Executive Summary - Chart on Incremental Growth
Exhibits8: Executive Summary - Data Table on Incremental Growth
Exhibits9: Executive Summary - Chart on Vendor Market Positioning
Exhibits10: Parent market
Exhibits11: Market Characteristics
Exhibits12: Offerings of vendors included in the market definition
Exhibits13: Market segments
Exhibits14: Chart on Global - Market size and forecast 2022-2027 ($ million)
Exhibits15: Data Table on Global - Market size and forecast 2022-2027 ($ million)
Exhibits16: Chart on Global Market: Year-over-year growth 2022-2027 (%)
Exhibits17: Data Table on Global Market: Year-over-year growth 2022-2027 (%)
Exhibits18: Historic Market Size - Data Table on global cell therapy market 2017 - 2021 ($ million)
Exhibits19: Historic Market Size - Type Segment 2017 - 2021 ($ million)
Exhibits20: Historic Market Size - Application Segment 2017 - 2021 ($ million)
Exhibits21: Historic Market Size - Geography Segment 2017 - 2021 ($ million)
Exhibits22: Historic Market Size - Country Segment 2017 - 2021 ($ million)
Exhibits23: Five forces analysis - Comparison between 2022 and 2027
Exhibits24: Chart on Bargaining power of buyers - Impact of key factors 2022 and 2027
Exhibits25: Bargaining power of suppliers - Impact of key factors in 2022 and 2027
Exhibits26: Threat of new entrants - Impact of key factors in 2022 and 2027
Exhibits27: Threat of substitutes - Impact of key factors in 2022 and 2027
Exhibits28: Threat of rivalry - Impact of key factors in 2022 and 2027
Exhibits29: Chart on Market condition - Five forces 2022 and 2027
Exhibits30: Chart on Type - Market share 2022-2027 (%)
Exhibits31: Data Table on Type - Market share 2022-2027 (%)
Exhibits32: Chart on Comparison by Type
Exhibits33: Data Table on Comparison by Type
Exhibits34: Chart on Autologous - Market size and forecast 2022-2027 ($ million)
Exhibits35: Data Table on Autologous - Market size and forecast 2022-2027 ($ million)
Exhibits36: Chart on Autologous - Year-over-year growth 2022-2027 (%)
Exhibits37: Data Table on Autologous - Year-over-year growth 2022-2027 (%)
Exhibits38: Chart on Allogenic - Market size and forecast 2022-2027 ($ million)
Exhibits39: Data Table on Allogenic - Market size and forecast 2022-2027 ($ million)
Exhibits40: Chart on Allogenic - Year-over-year growth 2022-2027 (%)
Exhibits41: Data Table on Allogenic - Year-over-year growth 2022-2027 (%)
Exhibits42: Market opportunity by Type ($ million)
Exhibits43: Data Table on Market opportunity by Type ($ million)
Exhibits44: Chart on Application - Market share 2022-2027 (%)
Exhibits45: Data Table on Application - Market share 2022-2027 (%)
Exhibits46: Chart on Comparison by Application
Exhibits47: Data Table on Comparison by Application
Exhibits48: Chart on Malignancies - Market size and forecast 2022-2027 ($ million)
Exhibits49: Data Table on Malignancies - Market size and forecast 2022-2027 ($ million)
Exhibits50: Chart on Malignancies - Year-over-year growth 2022-2027 (%)
Exhibits51: Data Table on Malignancies - Year-over-year growth 2022-2027 (%)
Exhibits52: Chart on Musculoskeletal - Market size and forecast 2022-2027 ($ million)
Exhibits53: Data Table on Musculoskeletal - Market size and forecast 2022-2027 ($ million)
Exhibits54: Chart on Musculoskeletal - Year-over-year growth 2022-2027 (%)
Exhibits55: Data Table on Musculoskeletal - Year-over-year growth 2022-2027 (%)
Exhibits56: Chart on Cardiovascular - Market size and forecast 2022-2027 ($ million)
Exhibits57: Data Table on Cardiovascular - Market size and forecast 2022-2027 ($ million)
Exhibits58: Chart on Cardiovascular - Year-over-year growth 2022-2027 (%)
Exhibits59: Data Table on Cardiovascular - Year-over-year growth 2022-2027 (%)
Exhibits60: Chart on Others - Market size and forecast 2022-2027 ($ million)
Exhibits61: Data Table on Others - Market size and forecast 2022-2027 ($ million)
Exhibits62: Chart on Others - Year-over-year growth 2022-2027 (%)
Exhibits63: Data Table on Others - Year-over-year growth 2022-2027 (%)
Exhibits64: Market opportunity by Application ($ million)
Exhibits65: Data Table on Market opportunity by Application ($ million)
Exhibits66: Analysis of price sensitivity, lifecycle, customer purchase basket, adoption rates, and purchase criteria
Exhibits67: Chart on Market share by geography 2022-2027 (%)
Exhibits68: Data Table on Market share by geography 2022-2027 (%)
Exhibits69: Chart on Geographic comparison
Exhibits70: Data Table on Geographic comparison
Exhibits71: Chart on North America - Market size and forecast 2022-2027 ($ million)
Exhibits72: Data Table on North America - Market size and forecast 2022-2027 ($ million)
Exhibits73: Chart on North America - Year-over-year growth 2022-2027 (%)
Exhibits74: Data Table on North America - Year-over-year growth 2022-2027 (%)
Exhibits75: Chart on Europe - Market size and forecast 2022-2027 ($ million)
Exhibits76: Data Table on Europe - Market size and forecast 2022-2027 ($ million)
Exhibits77: Chart on Europe - Year-over-year growth 2022-2027 (%)
Exhibits78: Data Table on Europe - Year-over-year growth 2022-2027 (%)
Exhibits79: Chart on Asia - Market size and forecast 2022-2027 ($ million)
Exhibits80: Data Table on Asia - Market size and forecast 2022-2027 ($ million)
Exhibits81: Chart on Asia - Year-over-year growth 2022-2027 (%)
Exhibits82: Data Table on Asia - Year-over-year growth 2022-2027 (%)
Exhibits83: Chart on Rest of World (ROW) - Market size and forecast 2022-2027 ($ million)
Exhibits84: Data Table on Rest of World (ROW) - Market size and forecast 2022-2027 ($ million)
Exhibits85: Chart on Rest of World (ROW) - Year-over-year growth 2022-2027 (%)
Exhibits86: Data Table on Rest of World (ROW) - Year-over-year growth 2022-2027 (%)
Exhibits87: Chart on US - Market size and forecast 2022-2027 ($ million)
Exhibits88: Data Table on US - Market size and forecast 2022-2027 ($ million)
Exhibits89: Chart on US - Year-over-year growth 2022-2027 (%)
Exhibits90: Data Table on US - Year-over-year growth 2022-2027 (%)
Exhibits91: Chart on Germany - Market size and forecast 2022-2027 ($ million)
Exhibits92: Data Table on Germany - Market size and forecast 2022-2027 ($ million)
Exhibits93: Chart on Germany - Year-over-year growth 2022-2027 (%)
Exhibits94: Data Table on Germany - Year-over-year growth 2022-2027 (%)
Exhibits95: Chart on UK - Market size and forecast 2022-2027 ($ million)
Exhibits96: Data Table on UK - Market size and forecast 2022-2027 ($ million)
Exhibits97: Chart on UK - Year-over-year growth 2022-2027 (%)
Exhibits98: Data Table on UK - Year-over-year growth 2022-2027 (%)
Exhibits99: Chart on China - Market size and forecast 2022-2027 ($ million)
Exhibits100: Data Table on China - Market size and forecast 2022-2027 ($ million)
Exhibits101: Chart on China - Year-over-year growth 2022-2027 (%)
Exhibits102: Data Table on China - Year-over-year growth 2022-2027 (%)
Exhibits103: Chart on Japan - Market size and forecast 2022-2027 ($ million)
Exhibits104: Data Table on Japan - Market size and forecast 2022-2027 ($ million)
Exhibits105: Chart on Japan - Year-over-year growth 2022-2027 (%)
Exhibits106: Data Table on Japan - Year-over-year growth 2022-2027 (%)
Exhibits107: Market opportunity by geography ($ million)
Exhibits108: Data Tables on Market opportunity by geography ($ million)
Exhibits109: Impact of drivers and challenges in 2022 and 2027
Exhibits110: Overview on Criticality of inputs and Factors of differentiation
Exhibits111: Overview on factors of disruption
Exhibits112: Impact of key risks on business
Exhibits113: Vendors covered
Exhibits114: Matrix on vendor position and classification
Exhibits115: Astellas Pharma Inc. - Overview
Exhibits116: Astellas Pharma Inc. - Product / Service
Exhibits117: Astellas Pharma Inc. - Key news
Exhibits118: Astellas Pharma Inc. - Key offerings
Exhibits119: Athersys Inc. - Overview
Exhibits120: Athersys Inc. - Product / Service
Exhibits121: Athersys Inc. - Key offerings
Exhibits122: Avita Medical Inc. - Overview
Exhibits123: Avita Medical Inc. - Product / Service
Exhibits124: Avita Medical Inc. - Key offerings
Exhibits125: BioCardia Inc. - Overview
Exhibits126: BioCardia Inc. - Product / Service
Exhibits127: BioCardia Inc. - Key offerings
Exhibits128: BioSenic SA - Overview
Exhibits129: BioSenic SA - Product / Service
Exhibits130: BioSenic SA - Key offerings
Exhibits131: Brainstorm Cell Therapeutics Inc. - Overview
Exhibits132: Brainstorm Cell Therapeutics Inc. - Product / Service
Exhibits133: Brainstorm Cell Therapeutics Inc. - Key offerings
Exhibits134: Bristol Myers Squibb Co. - Overview
Exhibits135: Bristol Myers Squibb Co. - Product / Service
Exhibits136: Bristol Myers Squibb Co. - Key news
Exhibits137: Bristol Myers Squibb Co. - Key offerings
Exhibits138: Capricor Therapeutics Inc. - Overview
Exhibits139: Capricor Therapeutics Inc. - Product / Service
Exhibits140: Capricor Therapeutics Inc. - Key offerings
Exhibits141: Castle Creek Biosciences Inc. - Overview
Exhibits142: Castle Creek Biosciences Inc. - Product / Service
Exhibits143: Castle Creek Biosciences Inc. - Key offerings
Exhibits144: CellSeed Inc. - Overview
Exhibits145: CellSeed Inc. - Product / Service
Exhibits146: CellSeed Inc. - Key offerings
Exhibits147: Cellular Biomedicine Group Inc. - Overview
Exhibits148: Cellular Biomedicine Group Inc. - Product / Service
Exhibits149: Cellular Biomedicine Group Inc. - Key offerings
Exhibits150: Celyad Oncology SA - Overview
Exhibits151: Celyad Oncology SA - Product / Service
Exhibits152: Celyad Oncology SA - Key offerings
Exhibits153: Gilead Sciences Inc. - Overview
Exhibits154: Gilead Sciences Inc. - Product / Service
Exhibits155: Gilead Sciences Inc. - Key news
Exhibits156: Gilead Sciences Inc. - Key offerings
Exhibits157: Lineage Cell Therapeutics Inc. - Overview
Exhibits158: Lineage Cell Therapeutics Inc. - Product / Service
Exhibits159: Lineage Cell Therapeutics Inc. - Key offerings
Exhibits160: Lisata Therapeutics Inc. - Overview
Exhibits161: Lisata Therapeutics Inc. - Product / Service
Exhibits162: Lisata Therapeutics Inc. - Key offerings
Exhibits163: Inclusions checklist
Exhibits164: Exclusions checklist
Exhibits165: Currency conversion rates for US$
Exhibits166: Research methodology
Exhibits167: Validation techniques employed for market sizing
Exhibits168: Information sources
Exhibits169: List of abbreviations